Home Tags MI130004

Tag: MI130004

MI130004 Shows Positive in vivo Activity against HER2-Expressing Tumors

Positive results of MI130004, a novel antibody-drug conjugate combining trastuzumab via Cys residues through a non-hydrolysable linker, with PM050489, a molecule of marine origin,...

MI130004 Demonstrates Anticancer Activity in HER2-expressing Tumors

Novel, effective, safe and efficient compounds of natural origin t help fight human disease are hard to find. ver the last decades, scientists have...

MI130004, a New ADC Using a Marine Compound, Shows Promising Therapeutic...

Over the last decade, antibody–drug conjugates or ADCs have emerged as powerful tool for the treatment of patients with cancer and hematological disorders.  These...

X